Euphrates Vascular
PrivateLast Round
Series B
Oct 3, 2023
Total Funding Raised
$17.34M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Euphrates Vascular operates in Healthcare & Life Sciences and is based in Saint Louis, Michigan. Its latest recorded funding round was a Series B round in October 2023.
Euphrates Vascular is a medical device company that develops and commercializes nanotechnology-based treatments for vascular occlusions, including Acute Ischemic Stroke, Peripheral Artery Disease, and ST-Elevated Myocardial Infarction.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Euphrates Vascular Comparables
Compare Euphrates Vascular with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Magneto Thrombectomy Solutions | 74% | |
| Endovascular Engineering, Inc. | 74% | |
| Stryker Corporation | 74% |
For institutional investors. Book with your work email.
Euphrates Vascular Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 3, 2023 | ||||
| Grant | Sep 1, 2022 | ||||
| Grant | Nov 20, 2018 | ||||
| Grant | Sep 1, 2016 | ||||
| VC Round | Jan 26, 2016 | ||||
VC Round | Apr 10, 2015 |
For institutional investors. Book with your work email.
Euphrates Vascular Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| FTL Capital LLC | VC Round |
| Cultivation Capital | VC Round |
| Missouri Technology Corporation | VC Round, Seed |
| +ND Capital | VC Round |
| St. Louis Arch Angels | VC Round |
| BioGenerator Ventures | Seed, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 677% MoM.
- Oct 3, 2023
$9.1M round with Billiken Angels Network and Central Illinois Angels.
For institutional investors. Book with your work email.
Euphrates Vascular Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Euphrates Vascular's valuation, stock price, and market status.
Is Euphrates Vascular a public or private company?
Euphrates Vascular is a private company.
What is the current stock price of Euphrates Vascular?
Euphrates Vascular is a private company, so its shares have no public market price. Caplight tracks Euphrates Vascular's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Euphrates Vascular worth (valuation)?
Valuation information for Euphrates Vascular is not publicly available.
Can I buy Euphrates Vascular stock?
Euphrates Vascular shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Euphrates Vascular's last funding round?
Euphrates Vascular's most recent funding round was Series B on October 3, 2023.
Who are the main investors in Euphrates Vascular?
Key investors in Euphrates Vascular include +ND Capital, BioGenerator Ventures.
Will Euphrates Vascular IPO soon?
No public IPO plans have been announced for Euphrates Vascular.
How can I track Euphrates Vascular secondary market activity?
Caplight tracks bids, offers, and trades in Euphrates Vascular's shares on secondary markets.